Search
Nektar Therapeutics
NKTRAdd to Watchlist
71.040USD
+6.650+10.33%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
2.09BMarket Cap
LossP/E TTM
Nektar Therapeutics Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
55.23M
-43.89%
EPS(YoY)
-9.73
-12.09%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its total revenue reached 55.23M, with a year-on-year change of -43.89.
What are the current assets of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its current assets were 266.27M, with a year-on-year change of 1.90.
What are the total assets of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its total assets of Nektar Therapeutics were 280.41M, with a year-on-year change of -7.72.
What are the total liabilities of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its total liabilities of Nektar Therapeutics were 190.57M, with a year-on-year change of -21.61.
What is the total equity of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its total equity of Nektar Therapeutics was 89.83M, with a year-on-year change of 47.90.
What is the net investment of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its net investment of Nektar Therapeutics was -1.20M, with a year-on-year change of -100.84.
What is the net financing of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its net financing of Nektar Therapeutics was 180.57M, with a year-on-year change of 328.71.
What is the Earnings Per Share (EPS) of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its Earnings Per Share (EPS) was -9.73, with a year-on-year change of -12.09.
What is the net margin of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its net profit margin was -297.07, with a year-on-year change of -145.79.
What is the gross margin of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its gross margin was 100.00, with a year-on-year change of 45.30.
What is the debt-to-asset ratio of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its debt-to-asset ratio was 22.52, with a year-on-year change of -25.43.
What is the Return on Equity (ROE) of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its Return on Equity (ROE) was -217.94, with a year-on-year change of -75.62.
What is the Return on Assets (ROA) of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its Return on Assets (ROA) was -56.17, with a year-on-year change of -65.69.
What is the operating profit of Nektar Therapeutics?
According to Nektar Therapeutics's FY2025 earnings report, its operating profit was -130.77M, with a year-on-year change of -0.66.